ML20138C648
| ML20138C648 | |
| Person / Time | |
|---|---|
| Issue date: | 04/10/1997 |
| From: | Lohaus P NRC OFFICE OF STATE PROGRAMS (OSP) |
| To: | GENERAL |
| References | |
| NACMUI, SP-97-026, SP-97-26, NUDOCS 9704300164 | |
| Download: ML20138C648 (4) | |
Text
. --
APR 101F/
ALL AGREEMENT AND NON-AGREEMENT STATES TRANSMITTAL OF STATE AGREEMENTS PROGRAM INFORMATION (SP-97-026 )
Your attention is invited to the enclosed correspondence which contains:
INCIDENT AND EVENT INFORMATION........
PROGRAM MANAGEMENT INFORMATION..
TRAINING COURSE INFORMATION............
TECH NIC AL INFORMATION.......................
OTH ER IN F O R M ATIO N . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .X X Vacancy Announcement for NRC Medical Advisory Committee Supplementary information: Enclosed for your information is a Federal Reaister Notice ,
inviting nominations for three positions on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Please note, that one of these positions is specifically allotted for an individual with a State or local government perspective. The names and addresses of the contact persons to submit nominations to and further information are listed on the Federal Renister Notice. Nominations are due May 23,1997.
If you have any questions regarding this correspondence, please contact me or the individual named below:
POINT OF CONTACT: Lloyd Bolling TELEPHONE: (301) 415-2327 l FAX: (301) 415-3502 l lNTERNET: LAB @NRC. GOV
' Original Signed by l Cardolia L'aupin Paul H. Lohaus, Deputy Director Office of State Programs
Enclosure:
~) /
As stated ._. g ~7 ,
' j Distribution:
DIR RF DCD (SP03)
SDroggitis PDR _(YES f_) (NO _)
All A/S File DOCUMENT NAME: G:\ LAB \SP97026 . LAB 'See previous concurrence.
Tge.w. . e.,, .: thi. 4.com.ni. indic.i. in in. boa: c - copy without .ti. chm nt/.nclosur. *E" = Copy with tt.chment/enclosur. 'N" = No copy OFFICE OSP OSP:DD l OSP:DGJ l l NAME LBolling:nb/gd PHLohaus RLBangarti P DATE 04/06/97* 04/07/97* 04(/l/97 OSP :lLE CODE: SP-A4 d U W .4 E - g dj y , .
~-
9704300164 970410 PDR STPRC ESGGEN PDR
ALL AGRE . ENT STATES OHIO, OKLAHOMA, PENNSYLVANIA TRANSMITTAL - STATE AGREEMENTS PROGRAM INFORMATION (SP )
Your attention is inv d to the enclosed correspondence which contains:
INCIDENT AND EV NT INFORMATION.........
PROGRAM MANAGE NT INFORMATION...
TRAINING COURSE INFO ATI O N. . . . .. . . . . . . .
TECHNICAL INFORM ATION.... ..................
OTHER INFORMATION................ ............. XX VACANCY ANNOUNCEMENT MEDICAL ADVISORY COMMITTEE Supplementary Information: Enclosed for you information is a Federal Reaister Notice inviting nominations for three positions on the A visory Committee on the Medical Uses of Isotopes. You should note, that one of these pos:Qons is specifically allotted for an individual with a State or local government perspect've. The names and addresses of the contact persons to submit nominations to and furthe information are listed on the Federal Reaister Notice. Nominations are due May 23,1997.
Paul H. Lohaus, Deputy Director
,4 Office of State Progr s Distribution:
DIR RF DC,3 (SPO3) RSAOs ) E-Mai .d SDroggitis PDR {YES f) (NO ,_) RSLOs ) / /97 l All A/S File DOCUMENT NAME: G:\ LAB \SP97MMM. LAB j T3 recalve a copy of thee document, Indicate in the boa: *C' = Copy w6thout attachment / enclosure "E" = Copy with attachment! enclosure *N* = No copy OFFICE OSP 4 l OQP1 DQ4 l OSP:D l l NAME LBolling:pWN > - PHLo@66 i RLBangart !
DATE - 04T(3 /97 04/1/97 04/ /97 OSP :lLE CODE: SP-A L ,
i pattrug g k UNITED STATES s" j NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 30N64001
+9 , , , , , ,o April 10, 1997 l l
1 ALL AGREEMENT AND NON-AGREEMENT STATES .
TRANSMITTAL OF STATE AGREEMENTS PROGRAM INFORMATION (SP-97-026)
Your attention is invited to the enclosed correspondence which contains:
INCIDENT AND EVENT INFORMATION........
PROGRAM MANAGEMENT INFORMATION..
TRAINING COURSE INFORMATION............
TECH NICAL INFORM ATION.......................
OTH ER IN FO R M ATIO N......... .....................XX Vacancy Announcement for NRC Medical Advisory Committee Supplementary Information: Enclosed for your information is a Eederal Reaister Notice inviting nominations for three positions on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Please note, that one of these positions is specifically allotted for an individual with a State or local government perspective. The names and addresses of the contact persons to submit nominations to and further information are listed on the Federal Reaister Notice. Nominations are due May 23,1997. ,
if you have any questions regarding this correspondence, please contact me or the individual named below:
1 POINT OF CONTACT: Lloyd Bolling TELEPHONE: (3011 415-2327 FAX: (301) 415-3502 INTERNET: LAB @NRC. GOV Paul H. Loh s, Deputy Director >
Office of te Programs ,
Enclosure:
As stated
. . l Fcdercl Raist:r / Vol. 62, No 56 / Monday. March 24, 1997 / Notices 13905 The underlying purpose of 10 CFR available for public inspection at the technical assistance in licensing. )
50.82(b)(6)is to desenbe the Commissior/s Public Document Room, inspection, and enforcement cases. I requirements that must be met for 2120 L Street NW. Washington. D.C. Committee members possess the license termination, one of which is that 20037. medical and technical skills needed to the results of the terminal survey and Copies of items (2). (3). and (4) may address evolving issues. Currently, the other documentation show that the be obtained upon receipt of a request ACMUI membership consists of:(a) facility and site rueet the requirements addressed to the U.S. Nuclear three practicing physicians;(b) a for release. These survey results and Regulatory Commission. Washington, physician representing the U.S.
documentation form part of the basis for D.C. 20555-0001, Attention: Director. Department of Health and Human I terminating the license. In this case, the Division of Reactor Program Services, Food and Drug remaining reactor components (the Management.
facility) will be released, but the site Administration:(c) a nuclear This exempdon is effective upon pharmacist; (d) two medical physicists will not be released. Because the site issuance. (nuclear medicine and therapy); (e) a will continue to be subject to the NRC Dated at Rockville. Maryland, this 14th day health care administrator; (f) a certified I March 1997. medical dosimetrist; and (g) a patients' p on o th athat e terminal For the Nuclear Regulatory Commission. rights and care advocate (whose term survey and other documentation must show that the site li suitable for release Samuel J. Collins, expires September 30.1997). Presently, is not necessary in order to terminate Director. O// ice ofNuclearReactor the specialties of the physicians on the the license. Regulation. ACMUI are: therapeutic radiology, with (FR Doc. 97-7338 Filed 3-21-97: 8:45 aml expertise in teletherapy and IV ,w,,a coo, nauw brachytherapy (two), and nuclear For the foregoing reasons, the NRC medicine researth (one). The staff is in staff has concluded that not requiring a the process of finalizing the terminal radiation survey and associated Nomirvdons of New Members of the appointment of a nominee for the documentation that demonstrate that Advisory Committee on the Medical posidon of nuclear medicine physician, the site is suitable for release as a Uses of Isetopes The U.S. Nuclear Regulatory condition of license termination will not Commission is inviting nominations for present an undue risk to public health Ac NCY: U.S. Nuclear Regulatory Commissi three positions on the Advisory and safety and is consistent with the . Committee on the Medical Uses of common defense and security. The NRC ACTION: Call for nominations. Isotopes (ACMUI). One position is for a l staff has determined that there ar Physician practicing nuclear cardiology, SuuuARY: The U.S. Nuclear Regulatory ied n 10 CFR 501 (a) )' in that Commission is inviting nominations for The second position is for a patients' three positions on the Advisory rights and care advocate. The third IIcati f of 10 CFR 5 82(b)( (1 )i ot necessary in order Committee on the Medical Uses of Position is for an individual with State 180 topes (ACMUI) to fill current and or local government perspect2ve.
to achieve the underlying purpose of this regulation. upcoming committee vacancies. One Nominees must include four copies of Accordingly, the Commission has Position is for a physician practicing their resumes, describing their determined that, pursuant to 10 CFR nuclear cardiology. The second posidon educational and p ofessional 50.12(a), an exempdon is authorized by is for a patients' rights and care qualifications, and provide their current law, will not endanger life or property advocate. The third position is for an addresses and telephone numbers.
or common defense and security, and is individual with State or local All new committee members will otherwise in the public interest. governmtat perspective. serve 3. year terms, with possible i Therefore, the Commission hereby DATES: Nominations are due May 23 reappointment to an additional 3-year grants an exemption from the 1997- term.
uirements of 10 CFR 50.82(b)(6)(ii) ADDRESSES: Submit nominations to: The at a termina ra lation survey and Nominees must be U.S. citizens and Office of Personnel. Atta: Ms. Jude be able to devote aPProximately 80 associated documentation demonstrates liimmelberB. Mall stopt 2D32. U.S-hours per year to committee business.
that the site is suitable for release are needed as a condition of Operating
g ission, Members will be compensated and w"a hi gt o, .
reimbursed for travel (including per License No. R-25 termination.
Pursuant to 10 CFR 51.32, the FOR FURTHER INFORMATION CONTACT: diem in lieu of subsistence), secretarial, Commission has determined that the William D. I tcCarthy, Office of Nuclear and correspondence expenses. l granting of this exemption will not have Material Safety and Safeguards, U.S. Nominees will undergo a security a significant effect on the quality of the Nuclear Regulatory Commission, backgnmnd check and will be required human environment (62 FR 11936). Washington, DC 20555, Telephone: to complete financial disclosure For further details with respect to this 301-415-7894. statements, to avoid conflict of interest action, see (1) the applicadon for SUPPLEMENTARY INFORMATION: The issues.
termination of Amended Facility ACMUl edvises NRC on policy and Dated at Rockville, Maryland, this leth day Operating License No. R-25, dated July technical issues that arise in regulatin8 of March,1997.
17,1990, as supplemented; (2) the the medical use of byproduct material For the U.S. Nuclear Regulatory Commission s safety evaluation related for diagnos,si and therapy.
to the termination of the liceose;(3) the Comun.en. .
Res environmental assessment and finding guibnsibilities include ce and comments on providing changes in ^"d " " ' 8*.
of no significant impact; and (4) the NRC rules, regulations, and guides Advisory Committee Management Officer. l Commission's Order terminating concerning medical use; evaluating Ollic' o/th* Sec'erary of the Commission. l Amended Facility Operating License certain non-routine uses of byproduct (FR Doc. 97-7316 Filed 3-21-97,8 45 aml No. R-25. Each of these items is material for medical use; and providing asumo coot new